This study investigates the expectations of people considering enrollment in an ocular (eye) gene transfer trial for X-linked retinoschisis (XLRS, an inherited eye disease caused by mutations in the RS1 gene). It included people over 18 with a molecular diagnosis of XLRS. It is an observational (non-phase) study and has been completed.
The summary above is a plain-language rendering of the official record. The original English title is shown for reference.
Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.
* INCLUSION CRITERIA: Participants may be eligible to take part in this study if they: * Are 18 years of age or older. * Have a molecular diagnosis of XLRS and are eligible to be screened for a Phase I/II ocular gene transfer clinical trial. * Are able to understand and comply with the procedures of this study. EXCLUSION CRITERIA: Participants may not be able to take part in this study if they: * Have eye findings or other medical conditions that would preclude consideration for participation in a Phase I/II ocular gene transfer clinical trial. * Are receiving experimental treatment for XLRS in another research study.